- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 38/49 - UrokinaseActivateur du plasminogène
Détention brevets de la classe A61K 38/49
Brevets de cette classe: 269
Historique des publications depuis 10 ans
|
15
|
8
|
20
|
25
|
25
|
24
|
13
|
12
|
15
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Talengen International Limited | 79 |
12 |
| Thornhill Therapeutics, Inc. | 31 |
10 |
| Remedy Pharmaceuticals, Inc. | 58 |
7 |
| Children's Medical Center Corporation | 1909 |
6 |
| National Jewish Health | 167 |
6 |
| PAION Deutschland GmbH | 15 |
6 |
| The Research Foundation for The State University of New York | 1657 |
6 |
| Board of Regents, The University of Texas System | 5921 |
5 |
| NoNO Inc. | 80 |
5 |
| Shimojani, LLC | 7 |
5 |
| Thrombolytic Science, LLC | 7 |
5 |
| The United States Government AS represented by The Department of Veterans Affairs | 1234 |
5 |
| Vertex Pharmaceuticals Incorporated | 1621 |
4 |
| Annexin Pharmaceuticals AB | 21 |
4 |
| Case Western Reserve University | 1844 |
4 |
| Rin Institute Inc. | 27 |
4 |
| Genentech, Inc. | 4006 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6522 |
3 |
| The Regents of the University of Michigan | 4768 |
3 |
| Hadasit Medical Research Services & Development Limited | 139 |
3 |
| Autres propriétaires | 163 |